www.fdanews.com/articles/138824-isis-cholesterol-drug-submitted-in-europe
Isis Cholesterol Drug Submitted in Europe
July 29, 2011
A cholesterol-lowering drug discovered and developed by Isis Pharmaceuticals has been submitted for market approval in Europe by the Carlsbad company’s partner, Genzyme, the drug developers said.
Sigon San Diego
Sigon San Diego